VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
11 hedge funds and large institutions have $19.7M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.29%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Goldman Sachs
New York
|
$81K |
2 |
VKH
2
Virtu KCG Holdings
New York
|
$48K |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$3K |
4 |
4
UBS Group
Zurich,
Switzerland
|
$1K |
5 |
5
Morgan Stanley
New York
|
$3K |
Top Sellers
1 |
1
Hudson Bay Capital Management
Stamford,
Connecticut
|
$2.79M |
2 |
2
Bank of America
Charlotte,
North Carolina
|
$0 |